Cargando…

Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients

BACKGROUND: During the early months of the coronavirus disease 2019 pandemic, risks associated with severe acute respiratory syndrome coronavirus 2 in pregnancy were uncertain. Pregnant patients can serve as a model for the success of clinical and public health responses during public health emergen...

Descripción completa

Detalles Bibliográficos
Autores principales: Lokken, Erica M., Taylor, G. Gray, Huebner, Emily M., Vanderhoeven, Jeroen, Hendrickson, Sarah, Coler, Brahm, Sheng, Jessica S., Walker, Christie L., McCartney, Stephen A., Kretzer, Nicole M., Resnick, Rebecca, Kachikis, Alisa, Barnhart, Nena, Schulte, Vera, Bergam, Brittany, Ma, Kimberly K., Albright, Catherine, Larios, Valerie, Kelley, Lori, Larios, Victoria, Emhoff, Sharilyn, Rah, Jasmine, Retzlaff, Kristin, Thomas, Chad, Paek, Bettina W., Hsu, Rita J., Erickson, Anne, Chang, Andrew, Mitchell, Timothy, Hwang, Joseph K., Gourley, Rebecca, Erickson, Stephen, Delaney, Shani, Kline, Carolyn R., Archabald, Karen, Blain, Michela, LaCourse, Sylvia M., Adams Waldorf, Kristina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884918/
https://www.ncbi.nlm.nih.gov/pubmed/33607103
http://dx.doi.org/10.1016/j.ajog.2021.02.011
_version_ 1783651514351353856
author Lokken, Erica M.
Taylor, G. Gray
Huebner, Emily M.
Vanderhoeven, Jeroen
Hendrickson, Sarah
Coler, Brahm
Sheng, Jessica S.
Walker, Christie L.
McCartney, Stephen A.
Kretzer, Nicole M.
Resnick, Rebecca
Kachikis, Alisa
Barnhart, Nena
Schulte, Vera
Bergam, Brittany
Ma, Kimberly K.
Albright, Catherine
Larios, Valerie
Kelley, Lori
Larios, Victoria
Emhoff, Sharilyn
Rah, Jasmine
Retzlaff, Kristin
Thomas, Chad
Paek, Bettina W.
Hsu, Rita J.
Erickson, Anne
Chang, Andrew
Mitchell, Timothy
Hwang, Joseph K.
Gourley, Rebecca
Erickson, Stephen
Delaney, Shani
Kline, Carolyn R.
Archabald, Karen
Blain, Michela
LaCourse, Sylvia M.
Adams Waldorf, Kristina M.
author_facet Lokken, Erica M.
Taylor, G. Gray
Huebner, Emily M.
Vanderhoeven, Jeroen
Hendrickson, Sarah
Coler, Brahm
Sheng, Jessica S.
Walker, Christie L.
McCartney, Stephen A.
Kretzer, Nicole M.
Resnick, Rebecca
Kachikis, Alisa
Barnhart, Nena
Schulte, Vera
Bergam, Brittany
Ma, Kimberly K.
Albright, Catherine
Larios, Valerie
Kelley, Lori
Larios, Victoria
Emhoff, Sharilyn
Rah, Jasmine
Retzlaff, Kristin
Thomas, Chad
Paek, Bettina W.
Hsu, Rita J.
Erickson, Anne
Chang, Andrew
Mitchell, Timothy
Hwang, Joseph K.
Gourley, Rebecca
Erickson, Stephen
Delaney, Shani
Kline, Carolyn R.
Archabald, Karen
Blain, Michela
LaCourse, Sylvia M.
Adams Waldorf, Kristina M.
author_sort Lokken, Erica M.
collection PubMed
description BACKGROUND: During the early months of the coronavirus disease 2019 pandemic, risks associated with severe acute respiratory syndrome coronavirus 2 in pregnancy were uncertain. Pregnant patients can serve as a model for the success of clinical and public health responses during public health emergencies as they are typically in frequent contact with the medical system. Population-based estimates of severe acute respiratory syndrome coronavirus 2 infections in pregnancy are unknown because of incomplete ascertainment of pregnancy status or inclusion of only single centers or hospitalized cases. Whether pregnant women were protected by the public health response or through their interactions with obstetrical providers in the early months of pandemic is not clearly understood. OBJECTIVE: This study aimed to estimate the severe acute respiratory syndrome coronavirus 2 infection rate in pregnancy and to examine the disparities by race and ethnicity and English language proficiency in Washington State. STUDY DESIGN: Pregnant patients with a polymerase chain reaction–confirmed severe acute respiratory syndrome coronavirus 2 infection diagnosed between March 1, 2020, and June 30, 2020 were identified within 35 hospitals and clinics, capturing 61% of annual deliveries in Washington State. Infection rates in pregnancy were estimated overall and by Washington State Accountable Community of Health region and cross-sectionally compared with severe acute respiratory syndrome coronavirus 2 infection rates in similarly aged adults in Washington State. Race and ethnicity and language used for medical care of pregnant patients were compared with recent data from Washington State. RESULTS: A total of 240 pregnant patients with severe acute respiratory syndrome coronavirus 2 infections were identified during the study period with 70.7% from minority racial and ethnic groups. The principal findings in our study were as follows: (1) the severe acute respiratory syndrome coronavirus 2 infection rate was 13.9 per 1000 deliveries in pregnant patients (95% confidence interval, 8.3–23.2) compared with 7.3 per 1000 (95% confidence interval, 7.2–7.4) in adults aged 20 to 39 years in Washington State (rate ratio, 1.7; 95% confidence interval, 1.3–2.3); (2) the severe acute respiratory syndrome coronavirus 2 infection rate reduced to 11.3 per 1000 deliveries (95% confidence interval, 6.3–20.3) when excluding 45 cases of severe acute respiratory syndrome coronavirus disease 2 detected through asymptomatic screening (rate ratio, 1.3; 95% confidence interval, 0.96–1.9); (3) the proportion of pregnant patients in non-White racial and ethnic groups with severe acute respiratory syndrome coronavirus disease 2 infection was 2- to 4-fold higher than the race and ethnicity distribution of women in Washington State who delivered live births in 2018; and (4) the proportion of pregnant patients with severe acute respiratory syndrome coronavirus 2 infection receiving medical care in a non-English language was higher than estimates of pregnant patients receiving care with limited English proficiency in Washington State (30.4% vs 7.6%). CONCLUSION: The severe acute respiratory syndrome coronavirus 2 infection rate in pregnant people was 70% higher than similarly aged adults in Washington State, which could not be completely explained by universal screening at delivery. Pregnant patients from nearly all racial and ethnic minority groups and patients receiving medical care in a non-English language were overrepresented. Pregnant women were not protected from severe acute respiratory syndrome coronavirus 2 infection in the early months of the pandemic. Moreover, the greatest burden of infections occurred in nearly all racial and ethnic minority groups. These data coupled with a broader recognition that pregnancy is a risk factor for severe illness and maternal mortality strongly suggested that pregnant people should be broadly prioritized for coronavirus disease 2019 vaccine allocation in the United States similar to some states.
format Online
Article
Text
id pubmed-7884918
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-78849182021-02-16 Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients Lokken, Erica M. Taylor, G. Gray Huebner, Emily M. Vanderhoeven, Jeroen Hendrickson, Sarah Coler, Brahm Sheng, Jessica S. Walker, Christie L. McCartney, Stephen A. Kretzer, Nicole M. Resnick, Rebecca Kachikis, Alisa Barnhart, Nena Schulte, Vera Bergam, Brittany Ma, Kimberly K. Albright, Catherine Larios, Valerie Kelley, Lori Larios, Victoria Emhoff, Sharilyn Rah, Jasmine Retzlaff, Kristin Thomas, Chad Paek, Bettina W. Hsu, Rita J. Erickson, Anne Chang, Andrew Mitchell, Timothy Hwang, Joseph K. Gourley, Rebecca Erickson, Stephen Delaney, Shani Kline, Carolyn R. Archabald, Karen Blain, Michela LaCourse, Sylvia M. Adams Waldorf, Kristina M. Am J Obstet Gynecol Original Research BACKGROUND: During the early months of the coronavirus disease 2019 pandemic, risks associated with severe acute respiratory syndrome coronavirus 2 in pregnancy were uncertain. Pregnant patients can serve as a model for the success of clinical and public health responses during public health emergencies as they are typically in frequent contact with the medical system. Population-based estimates of severe acute respiratory syndrome coronavirus 2 infections in pregnancy are unknown because of incomplete ascertainment of pregnancy status or inclusion of only single centers or hospitalized cases. Whether pregnant women were protected by the public health response or through their interactions with obstetrical providers in the early months of pandemic is not clearly understood. OBJECTIVE: This study aimed to estimate the severe acute respiratory syndrome coronavirus 2 infection rate in pregnancy and to examine the disparities by race and ethnicity and English language proficiency in Washington State. STUDY DESIGN: Pregnant patients with a polymerase chain reaction–confirmed severe acute respiratory syndrome coronavirus 2 infection diagnosed between March 1, 2020, and June 30, 2020 were identified within 35 hospitals and clinics, capturing 61% of annual deliveries in Washington State. Infection rates in pregnancy were estimated overall and by Washington State Accountable Community of Health region and cross-sectionally compared with severe acute respiratory syndrome coronavirus 2 infection rates in similarly aged adults in Washington State. Race and ethnicity and language used for medical care of pregnant patients were compared with recent data from Washington State. RESULTS: A total of 240 pregnant patients with severe acute respiratory syndrome coronavirus 2 infections were identified during the study period with 70.7% from minority racial and ethnic groups. The principal findings in our study were as follows: (1) the severe acute respiratory syndrome coronavirus 2 infection rate was 13.9 per 1000 deliveries in pregnant patients (95% confidence interval, 8.3–23.2) compared with 7.3 per 1000 (95% confidence interval, 7.2–7.4) in adults aged 20 to 39 years in Washington State (rate ratio, 1.7; 95% confidence interval, 1.3–2.3); (2) the severe acute respiratory syndrome coronavirus 2 infection rate reduced to 11.3 per 1000 deliveries (95% confidence interval, 6.3–20.3) when excluding 45 cases of severe acute respiratory syndrome coronavirus disease 2 detected through asymptomatic screening (rate ratio, 1.3; 95% confidence interval, 0.96–1.9); (3) the proportion of pregnant patients in non-White racial and ethnic groups with severe acute respiratory syndrome coronavirus disease 2 infection was 2- to 4-fold higher than the race and ethnicity distribution of women in Washington State who delivered live births in 2018; and (4) the proportion of pregnant patients with severe acute respiratory syndrome coronavirus 2 infection receiving medical care in a non-English language was higher than estimates of pregnant patients receiving care with limited English proficiency in Washington State (30.4% vs 7.6%). CONCLUSION: The severe acute respiratory syndrome coronavirus 2 infection rate in pregnant people was 70% higher than similarly aged adults in Washington State, which could not be completely explained by universal screening at delivery. Pregnant patients from nearly all racial and ethnic minority groups and patients receiving medical care in a non-English language were overrepresented. Pregnant women were not protected from severe acute respiratory syndrome coronavirus 2 infection in the early months of the pandemic. Moreover, the greatest burden of infections occurred in nearly all racial and ethnic minority groups. These data coupled with a broader recognition that pregnancy is a risk factor for severe illness and maternal mortality strongly suggested that pregnant people should be broadly prioritized for coronavirus disease 2019 vaccine allocation in the United States similar to some states. Elsevier Inc. 2021-07 2021-02-16 /pmc/articles/PMC7884918/ /pubmed/33607103 http://dx.doi.org/10.1016/j.ajog.2021.02.011 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Research
Lokken, Erica M.
Taylor, G. Gray
Huebner, Emily M.
Vanderhoeven, Jeroen
Hendrickson, Sarah
Coler, Brahm
Sheng, Jessica S.
Walker, Christie L.
McCartney, Stephen A.
Kretzer, Nicole M.
Resnick, Rebecca
Kachikis, Alisa
Barnhart, Nena
Schulte, Vera
Bergam, Brittany
Ma, Kimberly K.
Albright, Catherine
Larios, Valerie
Kelley, Lori
Larios, Victoria
Emhoff, Sharilyn
Rah, Jasmine
Retzlaff, Kristin
Thomas, Chad
Paek, Bettina W.
Hsu, Rita J.
Erickson, Anne
Chang, Andrew
Mitchell, Timothy
Hwang, Joseph K.
Gourley, Rebecca
Erickson, Stephen
Delaney, Shani
Kline, Carolyn R.
Archabald, Karen
Blain, Michela
LaCourse, Sylvia M.
Adams Waldorf, Kristina M.
Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients
title Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients
title_full Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients
title_fullStr Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients
title_full_unstemmed Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients
title_short Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients
title_sort higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884918/
https://www.ncbi.nlm.nih.gov/pubmed/33607103
http://dx.doi.org/10.1016/j.ajog.2021.02.011
work_keys_str_mv AT lokkenericam highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT taylorggray highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT huebneremilym highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT vanderhoevenjeroen highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT hendricksonsarah highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT colerbrahm highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT shengjessicas highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT walkerchristiel highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT mccartneystephena highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT kretzernicolem highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT resnickrebecca highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT kachikisalisa highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT barnhartnena highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT schultevera highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT bergambrittany highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT makimberlyk highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT albrightcatherine highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT lariosvalerie highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT kelleylori highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT lariosvictoria highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT emhoffsharilyn highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT rahjasmine highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT retzlaffkristin highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT thomaschad highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT paekbettinaw highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT hsuritaj highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT ericksonanne highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT changandrew highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT mitchelltimothy highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT hwangjosephk highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT gourleyrebecca highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT ericksonstephen highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT delaneyshani highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT klinecarolynr highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT archabaldkaren highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT blainmichela highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT lacoursesylviam highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT adamswaldorfkristinam highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients
AT highersevereacuterespiratorysyndromecoronavirus2infectionrateinpregnantpatients